2018 AAPM Annual Meeting
Back to session list

Session Title: Clinical Implementation of Proton Beam Scanning
Question 1: What is the most commonly used proton dose calibration protocol?
Reference:ICRU Report 78
Choice A:AAPM TG-51
Choice B:AAPM TG-16
Choice C:IAEA TRS 398
Choice D:ICRU 59
Question 2: Select the key quality assurance parameters for spot scanning proton beam delivery.
Reference:2015 AAPM Summer School Proceeding; Chapter 14
Choice A:Spot energy
Choice B:Spot intensity (dose/MU)
Choice C:Spot position
Choice D:Spot shape
Choice E:All of above
Question 3: What is the most reliable way to validate dose calculation in the treatment planning system?
Reference:2015 AAPM Summer School Proceeding; Chapter 14
Choice A:Perform dose measurements in animal tissues
Choice B:Create a set of SOBP plans to measure dose in water for various situations
Choice C:Perform film measurements
Choice D:Request IROC for TLD measurements
Question 4: A field optimized using SFO methods will:
Reference:Clinical Radiation Oncology, 3rd Addition
Choice A:Deliver a uniform dose throughout the entire target area
Choice B:Have equal spot intensities
Choice C:Be highly sensitive to small set-up errors
Choice D:Take an extremely long time to deliver
Question 5: The PTV concept is not fully applicable in proton therapy because:
Reference:Journal of the ICRU Vol 7 No 2 (2007) Report 78: Oxford University Press. doi:10.1093/jicru/ndn001
Choice A:Spot position accuracy of a proton beam is too large.
Choice B:Range uncertainty must be considered in units of water equivalent distances and not physical distances.
Choice C:The RBE in a proton beam can be higher than 1.1
Choice D:The lateral penumbra of the proton beam is much smaller than the distal penumbra
Question 6: True or False: MFO optimized fields are usually more robust to range uncertainty than SFO optimized fields.
Reference:A. Lomax Phys. Med. Biol. 44: (1999)
Choice A:True.
Choice B:False.
Question 7: Low dose envelope contribution is dominated:
Reference:Sawakuchi et al. Experimental characterization of the low-dose evelope of spot scanning proton beams, Phys Med Biol 55, 3467-3478, 2010
Choice A:by multiple Coulomb scattering (MCS) in the beamline and in phantom only
Choice B:by secondary particles from nuclear interaction in phantom only
Choice C:(a)for low energy proton beams and (b) for high energy proton beams
Choice D:Always Combination of (a) and (b)
Question 8: The Experimental methods that could be used for measurements of the low dose envelope are:
Reference:(1) Sawakuchi et al. Experimental characterization of the low-dose evelope of spot scanning proton beams, Phys Med Biol 55, 3467-3478, 2010; (2) Clasie et al, Golden beam data for proton pencil-beam scanning, Phys Med Biol 57, 1147-1158. 2012; (3) Pedroni et al, Experimental characterization and physical modeling of the dose distribution of scanned proton pencil beams, Phys Med Biol 50, 541-561,2005
Choice A:Field size factor – measuring output at the center of the square fields.
Choice B:Use concentric circles.
Choice C:Use of concentric squares.
Choice D:All of the above.
Question 9: Why might Correction factors be needed for integral depth dose curves?
Reference:Zhu et al, Commissioning dose computation models for spot scanning proton beams in water for a commercially available treatment planning system, Med Phys 40, 041723-1-15, 2013
Choice A:Because commercial available large parallel-plate chambers is not large enough.
Choice B:Because the low dose envelope extends far away from the central axis of the pencil beam.
Choice C:Monte Carlo simulation can be an effective way to generate these correction factors.
Choice D:All of the above.
Question 10: Considering the problems and roadblocks mentioned in the panel discussion, what do you think is the best strategy to hire people?
Reference:National Proton Conference on staffing level survey, Orlando, Florida 2017
Choice A:Physicists or dosimetrists with photon experience are preferred because backup photon plans may be needed before or during downtime.
Choice B:Extra staffing may be needed for shift flexibility and overhead in operating a proton center.
Choice C:Planning comparison or publications may be needed to justify the benefit of particle therapy.
Choice D:All of above.
Back to session list